Mechanisms of action of hypolipidaemic drugs;Mécanismes d'action des hypolipidémiants

Therapie

Volumn 55, Issue 6, 2000, Pages 661-668

  Luc, G ^a  

^a INSTITUT PASTEUR DE LILLE   (France)

Author keywords

Fibrate; Hypolipidaemic drugs; Resin; Statin

Indexed keywords

ANTILIPEMIC AGENT; APOLIPOPROTEIN A1; APOLIPOPROTEIN A2; APOLIPOPROTEIN C3; BILE ACID; CHOLESTEROL; COLESTYRAMINE; FIBRIC ACID DERIVATIVE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LIPOPROTEIN LIPASE; LOW DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN RECEPTOR; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; RESIN; RETINOID X RECEPTOR; STEROL REGULATORY ELEMENT BINDING PROTEIN; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG;

BILE ACID SYNTHESIS; CARDIOVASCULAR DISEASE; CELL LEVEL; CHOLESTEROL BLOOD LEVEL; DRUG MECHANISM; ENZYME INHIBITION; GENETIC TRANSCRIPTION; HUMAN; INTESTINE ABSORPTION; LIPOLYSIS; LIPOPROTEIN BLOOD LEVEL; NONHUMAN; PRIORITY JOURNAL; REVIEW;

ANTILIPEMIC AGENTS; CARDIOVASCULAR DISEASES; CHOLESTEROL; HUMANS; HYDROXYMETHYLGLUTARYL COA REDUCTASES; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; HYPERLIPIDEMIAS; MODELS, BIOLOGICAL; RISK FACTORS; TRANSCRIPTION FACTORS;

EID: 0034476936     PISSN: 00405957     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (17)

1. Guidelines for cholesterol management: Recommendations of the National Cholesterol Education Program's Adult Treatment Panel II
2. The low-density lipoprotein pathway in human fibroblasts: Relation between cell surface receptor binding and endocytosis of low-density lipoprotein
3. Hepatocellular transport and secretion of biliary lipids
4. Effects of bile acids and steroid/thyroid hormones on the expression of cholesterol 7 alpha-hydroxylase mRNA and the CYP7 gene in HepG2 cells
5. The effects of colestipol on the metabolism of very-low-density lipoproteins in man
6. Effects of cholestyramine and chenodeoxycholic acid on the metabolism of endogenous triglyceride in hyperlipoproteinemia
7. New lipid lowering drugs and new effects of old drugs
8. Sterol regulatory element-binding proteins: Activators of cholesterol and fatty acid biosynthesis
9. Asparagine-proline sequence within membrane-spanning segment of SREBP triggers intramembrane cleavage by site-2 protease
10. Peroxisome proliferator-activated receptor-alpha activators regulate genes governing lipoprotein metabolism, vascular inflammation and atherosclerosis
11. Peroxisome proliferator-activated receptor alpha in metabolic disease, inflammation, atherosclerosis and aging
12. Mechanism of action of fibrates on lipid and lipoprotein metabolism
13. Altered constitutive expression of fatty acid-metabolizing enzymes in mice lacking the peroxisome proliferator-activated receptor alpha (PPARalpha)
14. Peroxisome proliferator-activated receptor alpha activators improve insulin sensitivity and reduce adiposity
15. Opposite regulation of human versus mouse apolipoprotein A-I by fibrates in human apolipoprotein A-I transgenic mice
16. Fibrates increase human apolipoprotein A-II expression through activation of the peroxisome proliferator-activated receptor